GEODIS achieves IATA CEIV Pharma Certification in Hyderabad

GEODIS has achieved IATA CEIV Pharma certification for its Hyderabad facility, confirming compliance with international standards for handling pharmaceutical and healthcare shipments. The certification strengthens GEODIS’ healthcare logistics capabilities in Hyderabad, one of India’s leading pharmaceutical and life sciences hubs, supporting the movement of temperature-sensitive products. Hyderabad becomes part of GEODIS’ global network of 29 CEIV Pharma-certified sites, including nine across the Asia-Pacific and Middle East region, enhancing the company’s healthcare supply chain offering. GEODIS achieves IATA CEIV Pharma certification for its Hyderabad site in India, validating its ability to handle pharmaceutical and healthcare shipments to the highest international standards. The milestone strengthens the company’s healthcare logistics capabilities in one of India’s leading life sciences hubs and expands its global network of CEIV-certified facilities GEODIS, a global leader in transport and logistics, has achieved the IATA Center of Excellence for Independent Validators (CEIV) Pharma certification for its Hyderabad site, reinforcing its commitment to delivering world-class healthcare and life sciences logistics solutions. The certification validates that GEODIS’ Hyderabad operations, processes, infrastructure, and personnel meet rigorous international standards for handling pharmaceutical and healthcare shipments. The certification process includes comprehensive assessments of quality management systems, operational procedures, risk management practices, staff training, temperature-control capabilities, and regulatory compliance. Hyderabad widely recognised as one of India’s leading pharmaceutical and life sciences hubs, plays a critical role in supporting global healthcare supply chains. With this achievement, GEODIS further strengthens its ability to serve pharmaceutical manufacturers, biotechnology companies, and healthcare customers requiring specialised logistics solutions. “Hyderabad is one of the world’s most important pharmaceutical manufacturing and export hubs, making it a strategic location for our healthcare logistics network,” said Chris Cahill, Managing Director, Middle East and India Sub-continent, GEODIS. “This certification enhances our ability to support customers moving increasingly complex and temperature-sensitive healthcare products across global markets. It also reflects our continued investment in specialist infrastructure and expertise in India, where we now have more than 1,000 employees across 15 locations serving over 7,000 customers. As part of our wider network of 29 CEIV Pharma-certified sites globally – including nine in the Asia Pacific and Middle East Region – Hyderabad further strengthens the resilience and consistency of our healthcare offering for customers across Asia Pacific and beyond.” The achievement complements GEODIS’ broader healthcare logistics strategy, which combines specialised infrastructure, trained healthcare logistics professionals, advanced shipment visibility and stringent quality controls to support the safe movement of critical healthcare products worldwide.